Meta Pixel

BTG Upgrades Ambev After 13 Years, Sees Signs of Weakness at Heineken

Brazilian investment bank lifts its price target to R$20 and says the brewer’s premium portfolio has restored pricing power to the owner of Brahma, Skol and Corona.

By Brazil Stock Guide – BTG Pactual upgraded Ambev S.A. (ABEV3) to buy after more than a decade of caution on the stock, marking one of the most symbolic thesis changes in Brazil’s consumer sector. “Thirteen years later, we’re upgrading Ambev to Buy,” analysts Thiago Duarte and Guilherme Guttilla wrote in a report that raised the brewer’s price target to R$20 from R$17.

The shift is notable because it does not depend on a miraculous recovery in Brazilian beer consumption. BTG’s argument is more direct: Ambev has started to recover the variable that historically mattered most for its value creation — pricing power. “We don’t take this lightly,” the analysts wrote, acknowledging that the bank’s cautious stance on the stock had been one of its most consistent calls over the past several years.

Green fatigue

For BTG Pactual, Dutch brewer Heineken still owns a powerful brand in Brazil, but its growth cycle is starting to show signs of maturity. The green bottle remains aspirational, yet BTG sees a structural weakness outside the Heineken-Amstel axis: a portfolio that may be too narrow to compete across all price points, channels and drinking occasions.

Ambev, by contrast, has built a more granular shelf strategy, ranging from core beer and value brands to a broader premium portfolio that includes Brahma, Skol, Budweiser, Spaten, Corona, Stella, Beck’s, Bohemia and new alcohol-free, low-calorie and gluten-free versions. “The portfolio is the moat the competition lacks,” the analysts wrote. In a World Cup year, Ambev does not need only to sell more liters; it may be able to capture more reais per liter.

Pricing matters

According to BTG, Ambev — the brewer historically associated with the 3G Capital trio Jorge Paulo Lemann, Marcel Telles and Carlos Sicupira — still has roughly 50% share in premium beer, below the roughly 70% share it holds in the core segment.

The bank estimates that Ambev can capture 1.4 percentage points of real pricing gains per year in Brazil’s beer segment in the coming years. That matters because pricing flows through earnings with limited additional capital. “The pricing thesis and the ROIC thesis are the same thesis,” the analysts wrote, referring to return on invested capital.

Machine repaired

BTG forecasts consolidated revenue of R$92.5 billion in 2026, EBITDA of R$31.1 billion and net income of R$16.1 billion. By 2028, those estimates rise to revenue of R$105.3 billion, EBITDA of R$34.7 billion and net income of R$18.5 billion. Return on invested capital, which stood at 30.6% in 2025, would reach 37% in 2028.

The most forceful reading in the report is that Ambev has stopped being merely a defensive dividend stock and once again has a value-creation story. “The machine… is repaired,” the analysts wrote. BTG is not saying the company will return to its golden age of the 2000s, nor that Brazil’s beer market will suddenly deliver a surge in volumes. The bet is more disciplined: in a mature market, the brewer can create value by defending share, lifting average prices and using its portfolio as a competitive barrier.

There are risks. Beer consumption in Brazil is growing slowly, Heineken remains relevant and cost inflation may still pressure margins. Even so, BTG sees a more attractive risk-reward profile, supported by net cash, an estimated dividend yield of 7.1%, room for buybacks and optionality from a possible consolidation of the minority stake by AB InBev.

Leave a Reply

Discover more from Brazil Stock Guide

Subscribe now to keep reading and get access to the full archive.

Continue reading